ChIP-sequencing analysis of E2F transcription factor 2 reveals its role in various biological processes of rheumatoid arthritis synovial fibroblasts.


Journal

Bioscience trends
ISSN: 1881-7823
Titre abrégé: Biosci Trends
Pays: Japan
ID NLM: 101502754

Informations de publication

Date de publication:
11 May 2021
Historique:
pubmed: 7 5 2021
medline: 30 11 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

The development and progression of rheumatoid arthritis (RA) are complex and the pathogenesis of this disease is not fully understood. E2F transcription factor 2 (E2F2) affects the development and progression of many diseases. To identify the mechanisms underlying the role of E2F2 in RA, chromatin immunoprecipitation was performed followed by sequencing (ChIP-seq) using the E2F2 antibody. Gene Ontology (GO) analysis of differentially expressed genes (DEGs) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment of captured downstream target genes and Metascape analysis of 22 protein molecules partly elucidated the mechanism by which E2F2 affects the progression of RA. Results indicated that E2F2 affects the metabolism of RASFs and the development of ribosome synthesis as well as the stress response. Results indicated that E2F2 can affect multiple biological processes involving RASFs and indicate a unique possibility of targeting E2F2 in the treatment of RA.

Identifiants

pubmed: 33952803
doi: 10.5582/bst.2021.01046
doi:

Substances chimiques

E2F2 Transcription Factor 0
E2F2 protein, human 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-134

Auteurs

Luwen Li (L)

Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China.
Key Lab for Biotech-Drugs of National Health Commission, Ji'nan, China.
Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.

Yihang Zhang (Y)

Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China.
Key Lab for Biotech-Drugs of National Health Commission, Ji'nan, China.
Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.

Lin Wang (L)

Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China.
Key Lab for Biotech-Drugs of National Health Commission, Ji'nan, China.
Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.

Jihong Pan (J)

Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China.
Key Lab for Biotech-Drugs of National Health Commission, Ji'nan, China.
Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH